Inhibition of MD-1 Expression by Antisense Oligodeoxynucleotides and Its Impact on Skin Allograft Survival of Mouse

ZHANG Xin,CHEN Bi-cheng,CHANG Sheng,ZHOU Hong-min,DU Dun-feng,YUAN Jin,CHEN Zhong-hua Klaus
DOI: https://doi.org/10.3760/j:issn:0254-5101.2005.09.010
2005-01-01
Abstract:Objective To study the effects of specific antisense oligodeoxynucleotides (AS-ODN)on MD-1 expression and skin allograft survival. Methods Group 1, AS-ODNs and group 2, random ODN(R-ODN), were administrated by 100 μg/48 h×8 doses i.v, whereas the animals in group 3(positive control) and group 4(negative control) were given normal saline by 0.5 ml/48 h×8 doses i.v. C57BL/6 to BALB/c skin allograft model was employed in groups 1-3, and BALB/c to BALB/c skin graft model was employed in group 4, followed by the defined treatments from day 0. Recipients were sacrificed at day 11 after transplantation. The expression of MD-1 on splenocytes was determined by FACS. AlamarBlue was used to evaluate the proliferation of recipient splenocytes. The serum levels of IL-2 and IL-10 was detected by ELISA. Results The mean survival time(MST) of skin allografts in group 1 was significantly prolonged, but R-ODN treatment had no effect on it as compared with group 3(P0.05). AS-ODN inhibited MD-1 expression and lymphocyte proliferation, down-regulated serum level of IL-2 and of IL-10, but R-ODN treatment showed no significant influence upon these(P0.05, vs controls). The grafts from treatment groups showed clear tissue structure with very few lymphocytes, while group 2 showed severely histological lesions of rejection. Conclusion AS-ODN treatment efficiently inhibited MD-1 expression and significantly prolonged the survival time of skin allografts. The expression level of MD-1 may function as an indicator for rejection.
What problem does this paper attempt to address?